Page last updated: 2024-09-03

mitiglinide and glucagon-like peptide 1

mitiglinide has been researched along with glucagon-like peptide 1 in 2 studies

Compound Research Comparison

Studies (mitiglinide)	Trials (mitiglinide)	Recent Studies (post-2010) (mitiglinide)	Studies (glucagon-like peptide 1)	Trials (glucagon-like peptide 1)	Recent Studies (post-2010) (glucagon-like peptide 1)
120	30	50	9,484	1,208	6,374

Protein Interaction Comparison

Protein	Taxonomy	mitiglinide (IC50)	glucagon-like peptide 1 (IC50)
Glucagon-like peptide 1 receptor	Homo sapiens (human)		0.0051

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, KY; Nakamura, A; Nomoto, H; Ono, Y	1
Kamoshima, H; Nakamura, A; Nomoto, H; Ono, Y	1

Trials

1 trial(s) available for mitiglinide and glucagon-like peptide 1

Article	Year
Glycemic/metabolic responses to identical meal tolerance tests at breakfast, lunch and dinner in Japanese patients with type 2 diabetes mellitus treated with a dipeptidyl peptidase-4 inhibitor and the effects of adding a mitiglinide/voglibose fixed-dose c Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:13 Topics: Aged; Blood Glucose; Breakfast; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Drug Therapy, Combination; Female; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Insulin; Insulin Secretion; Isoindoles; Lunch; Male; Meals; Middle Aged; Postprandial Period	2014

Article

Year

Glycemic/metabolic responses to identical meal tolerance tests at breakfast, lunch and dinner in Japanese patients with type 2 diabetes mellitus treated with a dipeptidyl peptidase-4 inhibitor and the effects of adding a mitiglinide/voglibose fixed-dose c

Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:13

Topics: Aged; Blood Glucose; Breakfast; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Drug Therapy, Combination; Female; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Insulin; Insulin Secretion; Isoindoles; Lunch; Male; Meals; Middle Aged; Postprandial Period

2014

Other Studies

1 other study(ies) available for mitiglinide and glucagon-like peptide 1

Article	Year
The glycemic/metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:3 Topics: Aged; Blood Glucose; Breakfast; C-Reactive Protein; Diabetes Mellitus, Type 2; Drug Combinations; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Insulin; Isoindoles; Lunch; Male; Meals; Middle Aged; Postprandial Period; Triglycerides	2014

Article

Year

The glycemic/metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus.

Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:3

Topics: Aged; Blood Glucose; Breakfast; C-Reactive Protein; Diabetes Mellitus, Type 2; Drug Combinations; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Insulin; Isoindoles; Lunch; Male; Meals; Middle Aged; Postprandial Period; Triglycerides

2014